ARTICLE | Clinical News
LB1148 regulatory update
November 24, 2014 8:00 AM UTC
Leading BioSciences submitted a compassionate use IND to FDA for LB1148 to treat gastrointestinal breakdown and multi-organ failure resulting from Ebola infection. The company plans to begin 2 Phase I...